Journal Guide

The International Journal of Green Nanotechnology is a unique open access journal addressing important challenges and latest advances in the chemistry, physics, biology, engineering, and other scientific aspects of green nanotechnology as well as on their societal impact and the policies that have been or should be developed to address them. It has three primary foci: biomedicine, materials science and engineering, and physics and chemistry. This journal is a member of the Committee on Publication Ethics (COPE).

The International Journal of Nanomedicine is an international, peer-reviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. Reflecting the growing activity in this emerging specialty, the aim of this journal is to highlight research and development leading to potential clinical applications in the prevention and treatment of disease.

The International Journal of Pharmaceutics is the journal for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.Editorial PolicyThe over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher.Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.

International Journal of Pharmacy Practice (IJPP) publishes original research and review articles on all aspects of medicines management, policy, practice and education. Topics covered include:.

Journal of Aerosol Medicine and Pulmonary Drug Delivery is the only authoritative journal focusing on aerosol use in medicine, new drug delivery systems, cutting-edge research, and new innovative therapies and clinical applications. All aspects of aerosol research in medicine are covered including pulmonary drug delivery, airway reactivity and asthma treatment, inhalation of particles and gases in the respiratory tract, toxic effects of inhaled agents, and aerosols as tools for studying basic physiologic phenomena.

The Journal of Asian Natural Products Research (JANPR) publishes chemical and pharmaceutical studies in the English language in the field of natural product research on Asian ethnic medicine. The journal publishes work from scientists in Asian countries, e.g. China, Japan, Korea and India, including contributions from other countries concerning natural products of Asia. The journal is chemistry-orientated. Major fields covered are: isolation and structural elucidation of natural constituents (including those for non-medical uses), synthesis and transformation (including biosynthesis and biotransformation) of natural products, pharmacognosy, and allied topics. Biological evaluation of crude extracts are acceptable only as supporting data for pure isolates with well-characterized structures.All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by at least two expert referees. STARTaylor & Francis/Routledge are committed to the widest possible dissemination of its journals to non-profit institutions in developing countries. Our STAR initiative offers individual researchers in Africa, South Asia and many parts of South East Asia the opportunity to gain one month's free online access to 1,300 Taylor & Francis journals. For more information, please visit the STAR website. DisclaimerTaylor & Francis makes every effort to ensure the accuracy of all the information (the "Content") contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.

Nanotechnology, dealing with functional structures and materials smaller than 100nm, is emerging as a truly interdisciplinary research area spanning several traditional scientific disciplines. In keeping with the growing trend, there is a strong need for a platform to share original research related to applications of nanotechnology in biomedical fields. In order to fulfill this demand, Journal of Biomedical Nanotechnology (JBN) is being created as an international peer-reviewed periodical that covers applications of nanotechnology in all fields of life sciences. JBN publishes original full papers and timely state-of-the-art reviews with author's photo and biography, and short communications encompassing the fundamental and applied research aspects. To speed up the reviewing process, we will provide on-line refereeing of all articles submitted in electronic form.

Journal of Cardiovascular Translational Research (JCTR) is a premier journal in cardiovascular translational research.

JCTR is the journal of choice for authors seeking the broadest audience for emerging technologies, therapies and diagnostics, pre-clinical research, and first-in-man clinical trials. JCTR's intent is to provide a forum for critical evaluation of the novel cardiovascular science, to showcase important and clinically relevant aspects of the new research, as well as to discuss the impediments that may need to be overcome during the translation to patient care.

• Impact Factor: 3.062
• Authors receive a decision within 10 days, on average
• Fast OnlineFirst publication ahead of print

The Journal of Controlled Release publishes high-quality research from and for pharmaceutical and biomaterials scientists in academia and industry on drug delivery, including drug biological properties of drugs, drug release mechanisms, drug delivery routes, drug delivery vehicles, bioactive polymers and hydrogels for drug delivery, delivery approaches, tissue engineering, and molecular imaging. Each issue has gene delivery and nanomedicine sections along with the cover story.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

READ the journal http://www.sciencedirect.com/science/journal/17732247HERE

The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on controlled release, bioavailability and drug absorption, nanomedicines, gene delivery, tissue engineering, etc. Hot topics, related to manufacturing processes and quality control, are also welcomed.

ournal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs.Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.Journal of Drug Targeting also carries papers on the physiological and other biological barriers to delivery and targeting, and means of overcoming the barriers, for example, by penetration enhancers, and covers subjects such as extravasation, diffusion in tumours and target tissues, avoidance of the reticulo-endothelial system, and toxicity testing and licensing of novel delivery systems.The Journal’s life-time achievement award winners to date are: 2009: PP Speiser (Switzerland), 2008: G Gregoriadis (UK), 2007: H Maeda (Japan), 2006: H Ringsdorf (Germany), 2005: A T Florence (UK), 2004: R L Juliano (USA)Read More: http://informahealthcare.com/page/drt/Description.